Genticel names VP, supervisory board
This article was originally published in Scrip
Executive Summary
Genticel, a biopharmaceutical company developing vaccines for patients infected with human papillomavirus, has named Dr Gerald Moeller vice-president of its supervisory board. Prior to joining the Toulouse, France-based firm's board Dr Moeller was an investment adviser at HBM Partners in Switzerland. Dr Moeller chairs the supervisory boards of a number of health sector companies, including 4Sigma, Definien, Invendo-Medical GmbH and MorphoSys. He is also a board member with FIND Foundation and Illumina. Genticel's supervisory board is currently chaired by Professor Thierry Hercend.